Fingerpaint, biopharma’s global commercialization partner for analytics-enabled integrated solutions, has acquired two companies as it continues to expand.
One company acquired is Engage, a London-based, award-winning, data and analytics–enabled healthcare marketing firm.
The MedThink, a North Carolina–based company that empowers healthcare providers through medical communications.
Engage will expand Fingerpaint’s European footprint and complement the company’s current data and analytics expertise.
The acquisition of MedThink will bring extensive medical communications capabilities to Fingerpaint through 2 distinct divisions: MedThink SciCom, which harnesses deep scientific knowledge and extensive industry experience to develop solutions for medical affairs, medical communications, and publication groups; and MedThink Communications, which provides medical education and marketing services that influence perception and change the behavior of healthcare professionals to commercial teams of all sizes.
“Strengthening our global infrastructure is reflective of the diversified biopharma industry we serve worldwide,” said Ed Mitzen, founder of Fingerpaint about Engage. “Our combined global omnichannel marketing solutions guided by—and rooted in—data will further Fingerpaint’s position as a transformative digital partner to biopharma’s commercialization needs.”
Mary McGregor and Dave Chandler, both founders and managing partners of Engage, will continue to lead day-to-day operations.
“Integrating into Fingerpaint will allow us to leverage its award-winning creative and digital talent and maximize omnichannel campaigns as we continue to work with global brands at every stage of the commercialization process,” said McGregor.
“Combining our expertise with Fingerpaint’s will create best-in-class, performance-based digital capabilities for clients across the company’s integrated firms,” said Chandler.
Knox Lane, a private equity firm based in San Francisco, is a strategic investor in Fingerpaint.
“Engage will help expand the data and analytics capabilities the industry has come to expect from Fingerpaint, biopharma’s leading commercialization partner,” said Shamik Patel, partner at Knox Lane.
Engage joins integrated Fingerpaint firms MedThink, a company that empowers healthcare providers through medical communications; Leaderboard Branding, a leading global naming and branding business; 1798, a market access and commercialization firm that specializes in healthcare consulting services, including patient and provider access services; and Photo 51, a consultancy focused solely on advanced therapeutics, such as gene and cell therapies.
Regarding MedThink, Mitzen said, “Adding to our capabilities as our clients’ needs evolve has always been a priority for Fingerpaint. Medical communications and education have never been more important than they are now given the ever-changing ways we reach healthcare stakeholders and the growing need to convey increasingly complex science behind many of today’s therapies to ensure people have access to them.”
Scott Goudy, president of MedThink, will continue to lead day-to-day operations.
“Joining Fingerpaint will accelerate our mission of moving minds, moving markets, and moving medicine by leveraging the company’s capabilities at every step of the commercialization process,” said Goudy. “We are looking forward to creating new opportunities for our clients and our people.”
“This acquisition will expand the company’s service offerings and talent into an area we know is critical to the industry and will solidify Fingerpaint’s position as biopharma’s leading commercialization partner,” said Patel of Knox Lane.
Engage and MedThink join integrated Fingerpaint firms Leaderboard Branding, a leading global naming and branding business; 1798, a market access and commercialization firm that specializes in healthcare consulting services, including patient and provider access services; and Photo 51, a consultancy focused solely on advanced therapeutics, such as gene and cell therapies.
Engage is a London-based, award-winning, data and analytics–enabled healthcare marketing firm. It delivers global omnichannel marketing solutions powered by advanced data insights to deliver customer engagement strategies, content and tech development, campaign deployment, and real-time performance analysis.
MedThink empowers healthcare providers through medical communications built on a foundation of science, strategy, and innovation. It has two distinct divisions: MedThink SciCom, which harnesses deep scientific knowledge and extensive industry experience to develop solutions for medical affairs, medical communications, and publication groups; and MedThink Communications, which provides medical education and marketing services that influence perception and change the behavior of healthcare professionals to commercial teams of all sizes.
Fingerpaint is an award-winning global team of more than 700 people who are committed to creating and executing meaningful brand experiences for healthcare providers, care partners, and patients.
Fingerpaint was named 2021 Agency of the Year by Med Ad News, and in 2018, it won the Heart Award from Med Ad News for its commitment to philanthropy and social causes. Additionally, it has been on Inc. Magazine’s list of the 5,000 Fastest-Growing Companies for the past eight years.